Coming up: Researchers discuss vaccine development, continued efforts on novel coronavirus
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
A vaccine candidate for the novel coronavirus hit a new milestone and entered phase two of clinical trials last week. But what does that mean in terms of how soon this vaccine — or others — might be ready for public use?
This vaccine is far from the only trial underway, with researchers around the world racing to safely produce a product — or products — to protect against COVID-19 infection.
Join Kerri Miller on our weekly show focusing on the science of the novel coronavirus as she talks with a vaccinologist and a virologist about how the vaccine development process works; the speed of the science happening during a pandemic; and answer listener questions.
Guests:
Deborah Fuller is a vaccinologist and professor of microbiology at the University of Washington School of Medicine
Angela Rasmussen is a virologist and associate research scientist at Columbia University’s Mailman School of Public Health.
Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.